Estrogen is a known risk factor in human breast cancer. In rodent models, estradiol has been shown to induce tumors in those tissues in which this hormone is predominantly converted to the catechol metabolite 4-hydroxyestradiol by a specific 4-hydroxylase enzyme, whereas tumors fail to develop in organs in which 2-hydroxylation predominates. We have now found that microsomes prepared from human mammary adenocarcinoma and fibroadenoma predominantly catalyze the metabolic 4-hydroxylation of estradiol (ratios of 4-hydroxyestradiol/2-hydroxyestradiol formation in adenocarcinoma and fibroadenoma, 3.8 and 3.7, respectively). In contrast, microsomes from normal tissue obtained either from breast cancer patients or from reduction mammoplasty operations expressed comparable estradiol 2-and 4-hydroxylase activities (corresponding ratios, 1.3 and 0.7, respectively). An elevated ratio of 4-/2-hydroxyestradiol formation in neoplastic mammary tissue may therefore provide a useful marker of benign or malignant breast tumors and may indicate a mechanistic role of 4-hydroxyestradiol in tumor development.
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The prolonged exposure of women to high estrogen levels has been associated with an elevated incidence of breast cancer (1, 2) . Thus, risk factors for this disease include high serum or urinary estrogen concentrations (3) (4) (5) , the early onset of menstruation, and late menopause (1, 2) . In rodent models, in which the natural hormone estradiol (E2) induces tumors, there is a differential formation of the two catechol metabolites, 2-and 4-hydroxyestradiol (2-and 4-OH-E2, respectively), which correlates with the organ's resistance or susceptibility to estrogen-induced carcinogenesis. Thus, in Syrian hamster kidney, CD-1 mouse uterus, and rat pituitary, all susceptible to tumor induction by E2 (6-8), 4-OH-E2 formation predominates, whereas in these rodents' livers, where tumors are not induced under these conditions, 2-hydroxylation of E2 predominates (9) (10) (11) . By analogy, in human uterine myoma, 4-hydroxylation of E2 by a distinct and specific estrogen 4-hydroxylase activity predominates over that in surrounding myometrium and over 2-hydroxylation in either tissue (12) .
Moreover, in human MCF-7 breast cancer cells, the formation of 4-OH-E2 is catalyzed by cytochrome P450 IB1 and is inducible by 2,3,7,8-tetrachlorodibenzo-p-dioxin, a common environmental pollutant (13) . In contrast, microsomal preparations from human liver or placenta catalyze the oxidation of E2 mainly to 2-OH-E2 with <-20% 4-OH-E2 formation (12, (14) (15) (16) (17) . This hepatic formation of catecholestrogen metabolites is catalyzed mainly by the cytochrome P450 IIIA family of enzymes, which generates -85% 2-OH-E2 and, in addition, -15% 4-OH-E2 due to a lack of enzyme specificity (14) (15) (16) (17) (18) (19) (21) . Microsomal pellets were resuspended in storage buffer (0.25 M sucrose/10 mM EDTA, pH 7.5) and frozen in aliquots at -80°C until used. Protein concentrations were determined by the method of Bradford using bovine serum albumin as standard (22) .
Microsome-Mediated Catechol Estrogen Formation. A validated direct product isolation assay was used to determine rates of catechol estrogen formation. The assay method and its validation have been described in detail (23 (13) and in human uterine myoma (12) , but not in liver (24, 25) , and which has been shown to catalyze the specific 4-hydroxylation of E2 (12, 13 (13) , and in human uterine myoma (12) but not in livers of these species has been taken as evidence that this metabolite may mediate the induction of tumors by steroidal estrogens (9, 20) . 4-Hydroxyestrogens may generate potentially mutagenic free radicals by metabolic redox cycling between the quinone, semiquinone, and hydroquinone (catechol estrogen) forms (20, 27, 28) . Evidence for free radical damage by redox cycling of estrogens includes single-strand breaks of DNA in MCF-7 cells induced by estrone-3,4-quinone (29) . Moreover, 4-OH-E2 induces single-strand breaks of DNA in hamster kidney and hydroxy radical-mediated 8-hydroxylation of guanine bases of DNA in vitro and in hamsters in vivo (30) (31) (32) 
